Patents by Inventor Dennis Lanfear

Dennis Lanfear has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PPAR-gamma AGONIST FOR TREATMENT OF BONE DISORDERS
    Publication number: 20190167660
    Abstract: Methods of treatment of bone disorders, including osteoporosis or its symptoms, with PPAR? agonists, and in particular, the compound of formula (I) known as INT131: (I)
    Type: Application
    Filed: August 18, 2017
    Publication date: June 6, 2019
    Inventor: Dennis Lanfear
  • Antidiabetic Solid Pharmaceutical Compositions
    Publication number: 20170273969
    Abstract: Provided are pharmaceutical compositions in solid form comprising a selective modulator of PPAR-? suitable for oral dosage to treat subjects having PPAR-? mediated conditions. Provided further are methods of manufacturing the compositions, and methods of treating a PPAR-? mediated condition.
    Type: Application
    Filed: June 12, 2017
    Publication date: September 28, 2017
    Inventors: Kathleen M. Lee, Linda Higgins, Dennis Lanfear
  • Solid pharmaceutical compositions of ppary modulator
    Patent number: 9675603
    Abstract: Provided are pharmaceutical compositions in solid form comprising a selective modulator of PPAR-? suitable for oral dosage to treat subjects having PPAR-? mediated conditions. Provided further are methods of manufacturing the compositions, and methods of treating a PPAR-? mediated condition.
    Type: Grant
    Filed: September 19, 2011
    Date of Patent: June 13, 2017
    Assignee: InteKrin Therapeutics, Inc.
    Inventors: Kathleen M. Lee, Linda Higgins, Dennis Lanfear
  • Combination of PPARy Agonist and a Dipeptidyl Peptidase-Inhibitor for the Treatment of Diabetes and Obesity
    Publication number: 20130245024
    Abstract: The present invention relates to pharmaceutical compositions and methods for the treatment of diabetes, obesity or disorders related to diabetes or obesity. The compositions comprise a combination of a particular PPAR? agonist and a particular dipeptidyl peptidase-IV (DPP-IV) inhibitor. The methods include the administration of the combination of a particular PPAR? agonist and a particular dipeptidyl peptidase-IV (DPP-IV) inhibitor.
    Type: Application
    Filed: March 6, 2009
    Publication date: September 19, 2013
    Inventors: Dennis Lanfear, Linda Higgins
  • Antidiabetic Solid Pharmaceutical Compositions
    Publication number: 20130243865
    Abstract: Provided are pharmaceutical compositions in solid form comprising a selective modulator of PPAR-Y suitable for oral dosage to treat subjects having PPAR-Y mediated conditions. Provided further are methods of manufacturing the compositions, and methods of treating a PPAR-Y mediated condition.
    Type: Application
    Filed: September 19, 2011
    Publication date: September 19, 2013
    Applicant: Intekrin Therapeutics, Inc., INC.
    Inventors: Kathleen M. Lee, Linda Higgins, Dennis Lanfear
  • COMBINATION OF A SELECTIVE PPAR-GAMMA MODULATOR AND AN INCRETIN FOR THE TREATMENT OF DIABETES AND OBESITY
    Publication number: 20110034380
    Abstract: The present invention relates to pharmaceutical compositions and methods for the treatment of diabetes, obesity or disorders related to diabetes or obesity. The compositions comprise a combination of a selective PPAR? modulator and an incretin. The methods include the administration of the combination of a selective PPAR? modulator and an incretin.
    Type: Application
    Filed: August 5, 2010
    Publication date: February 10, 2011
    Inventors: Dennis Lanfear, Linda Higgins